Article
Genome-wide association study of the response of patients with diabetic macular edema to intravitreal Anti-VEGF injection
29 Dec 2022
Abstract excerpt
Abstract Diabetic macular edema (DME), a complication of diabetes mellitus, is a leading cause of adult-onset blindness worldwide. Recently, intravitreal anti-VEGF injection has been used as a first-line treatment. This study analyzed the association between the genetic profile of patients with DME and their response to treatment. Intravitreal anti-VEGF injections were administered monthly for three months to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
